You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《股海通胜》石药急挫12838购 美团整固61434牛
阿思达克 11-29 13:39

中国外交部昨日强烈谴责美方签署《香港人权与民主法案》,市场担忧贸谈恐受影响,同时亦观望中方将采取何种反制措施,拖累恒指期结後裂口急跌188点後跌幅曾扩大至逾550点,失守26400点关口,穿10天及50天线。恒指半日收跌530点,报26364点,投资者若看好可留意恒指牛证59639,收回价26038点,杠杆约62倍,换股比率10000:1。看淡或对冲留意恒指熊证61167,收回价27060点,杠杆约31倍,换股比率10000:1。

内地公布医保新增药品名单,相关药品均价降60.7%,内地医药股受压,其中石药集团(01093)跌穿50天线半日插逾11%,曾触及一个月低位约17.3元。投资者若博反弹可留意石药购证12838,行使22.8元,实际杠杆5.22倍,到期日20年5月。看淡或对冲留意石药沽证11356,行使价14.12元,实际杠杆3.91倍,到期日20年6月。

阿里巴巴(BABA)今开盘短暂创下上市高位後失守200元关口,暂跌2.15%。市场预期阿里巴巴短时间内染蓝无望,或需待明年第三季度才有望纳入恒生指数和港股通。投资者若看好可留意阿里购证13488,行使价195.8元,实际杠杆3.84倍,到期日20年9月。续看淡或对冲可留意升幅暂逾一成的巴巴沽证10078,行使价145美元,实际杠杆9.32倍,到期日20年1月。

连升数日後美团点评(03690)今回吐逾4%,暂时於102元左右整固。向下支持可参考10天线约98元,向上观望能否有重回106元的机会。北水已连续24日累计买入美团约122亿元,投资者若看好博反弹可留意美团牛证61434,收回价93.6元,实际杠杆7.84倍,到期日20年5月。续看淡留意美团熊证62722,收回价110.8元,实际杠杆8.49倍,到期日20年5月。

《海通国际股票衍生产品部》

请参阅:www.htiwarrants.com

注:本资料之内容由从事证券及期货条例(Cap.571)中第一类(证券交易)及第四类(就证券提供意见)受规管活动之持牌法团–海通国际证券有限公司(「海通国际 )所编制及发行,唯并不代表资料内容已获香港证券及期货事务监察委员会审批。本资料的任何内容仅供参考,并不构成对任何投资买卖的邀请或招揽、建议或推荐。结构性产品如认股证及/或牛熊证的价格可跌可升,过往的表现并非未来表现的指标。结构性产品的价值可在到期时或到期前变成零,投资者因而引致投资全盘损失。牛熊证设有强制收回机制,因此有可能提早终止,在此情况下(i)N类牛熊证投资者会损失於牛熊证的全部投资;而(ii)R类牛熊证之剩证之剩余价值则可能为零。由海通国际或其联属公司所发行的结构性产品是没有相应抵押品,投资者应当自行留意发行商的偿债能力,以判断发行商是否有能力履行其所发行的结构性产品内应负之责任和义务。如发行人无力偿债或违约,投资者可能无法收回部份或全部应收款项。投资前,投资者应仔细参阅认股证及/或牛熊证的有关上市档(及任何该档之附录)及有关补充上市档所载的详情(包括风险因素),充份了解产品的性质及风险,考虑投资是否适合投资者的个别情况,如有需要,应谘询专业顾问。海通国际为本资料提及之证券的认股证及/或牛熊证(「结构性产品」)之流通量提供者,亦可能是唯一在交易所为结构性产品提供买卖报价的一方, 因此结构性产品之第二市场可能有限。海通国际(连同其附属及其联属公司,统称「海通国际集团」)真诚努力确保所提供资料正确和完整,惟海通国际集团并不保证该等资料的完整性及准确性,亦不对任何资料的不准确或遗漏负上任何责任。海通国际证券有限公司乃海通国际证券集团成员并因此同属於海通证券股份有限公司。海通国际证券有限公司为此文提及之证券及/或该证券的衍生产品进行庄家活动。~重要声明:

以上资讯由第三方提供,AASTOCKS.com Limited对於任何包含於、经由、连结、下载或从任何与本网站有关服务所获得之资讯、内容或广告,不声明或保证其内容之正确性或可靠性。对於您透过本网站上之广告、资讯或要约而展示、购买或取得之任何产品、资讯资料,本公司亦不负品质保证之责任。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account